0 Yorumlar
0 hisse senetleri
1K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Carglumic Acid Market, Growth, Competitive Landscape, Regional Outlook And Covid-19 Impact Analysis by Fact MRThe global market for carglumic acid is expected to increase from US$ 152.5 million in 2023 to US$ 314.4 million in 2033, according to Fact.MR. This represents a CAGR between 2023 and 2033 of more than 7.5%. The creation of novel treatments and ongoing innovation are what define the global pharmaceutical and healthcare sectors. Carglumic Acid, a drug used to treat a rare metabolic condition...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Carglumic Acid Market, Revenue Analysis & Region And Country Forecast by Fact MRFact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, a company that offers market research and competitive intelligence, the demand for carglumic acid in the global market is expected to reach US$ 152.5 million in 2023 and increase at a CAGR of 7.5% from 2023 to 2033. The use of carglumic acid in the treatment of urea...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
How Do Price Fluctuations Affect the Carglumic Acid Market?Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
How Does Carglumic Acid Compare to Alternative Treatments?Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
Sponsorluk
google-site-verification: google037b30823fc02426.html
Sponsorluk